Steatohepatitis/Metabolic Liver Disease
Article first published online: 9 SEP 2009
Copyright © 2009 American Association for the Study of Liver Diseases
Volume 51, Issue 2, pages 445–453, February 2010
How to Cite
Ratziu, V., Charlotte, F., Bernhardt, C., Giral, P., Halbron, M., LeNaour, G., Hartmann-Heurtier, A., Bruckert, E., Poynard, T. and LIDO Study Group (2010), Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial. Hepatology, 51: 445–453. doi: 10.1002/hep.23270
Members of the LIDO Study Group are listed in the acknowledgments.
ClinicalTrial.gov identifier number: NCT00492700.
Conflict of interest: This was an investigator initiated trial and GlaxoSmithKline Pharmaceuticals had no direct or indirect involvement in the design of the trial, data collection or preparation, or submission of the article. GSK provided rosiglitazone for this trial and partly funded the trial. None of the authors has a personal conflict of interest with the manufacturers of any of the marketed glitazones. V.R. is a consultant to Astellas, Axcan, Gilead, Genentech, Intercept, and Sanofi-Aventis. T.P. is a consultant for and owns 15% of Biopredictive, a company that markets FibroTest and SteatoTest. These conflicts of interest have been disclosed to study participants.
- Issue published online: 25 JAN 2010
- Article first published online: 9 SEP 2009
- Accepted manuscript online: 9 SEP 2009 12:00AM EST
- Manuscript Accepted: 25 AUG 2009
- Manuscript Received: 13 MAY 2009
Additional Supporting Information may be found in the online version of this article.
|HEP_23270_sm_SupFig.tif||537K||Supporting Figure 1. Time course of changes in HOMA score during the randomized and the extension phase of the FLIRT trial. *: included in the open-label, extension trial.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.